Eugenia Pankevich
Project Manager
Eugenia is a technology developer and cancer immunotherapy scientist. During her PhD in the Bock Lab, she co-led the project on “Systematic discovery of CRISPR-boosted CAR T cells” (Datlinger, Pankevich, Arnold et al., Nature 2025), where she developed the CELLFIE platform for genetic screens in human primary immune cells and identified novel candidates for potential clinical translation.
As a Postdoc and Project Manager, Eugenia’s current focus is to advance the identified enhanced T cell therapy designs toward the clinic.
Eugenia holds an M.Sc. degree in Bioengineering and Bioinformatics from Lomonosov Moscow State University, Russia. Prior to joining the lab, she completed her master’s project in 2018 at EPFL, Switzerland. Her long-term goal is to discover and translate innovative disease treatments.